{"gene":"RAP1A","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1995,"finding":"Crystal structure of Rap1A (GppNHp-bound) in complex with the Ras-binding domain (RBD) of c-Raf1 resolved to 2.2 Å, showing that RBD adopts a ubiquitin superfold and that the interaction is mediated by an antiparallel beta-sheet formed between RBD strands B1-B2 and Rap1A strands β2-β3, with switch I effector residues of Rap1A providing main-chain and side-chain contacts.","method":"X-ray crystallography (2.2 Å resolution)","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with detailed interface description, landmark study widely replicated","pmids":["7791872"],"is_preprint":false},{"year":1990,"finding":"Rap1A-p21 (Krev-1 product) binds tightly to Ras-GAP in a GTP-dependent manner but is not activated by GAP; it competitively inhibits GAP-mediated Ras GTPase activity, suggesting the mechanism by which Krev-1 suppresses Ras transformation.","method":"In vitro GTPase activity assay, competitive inhibition kinetics with purified proteins","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro biochemical reconstitution with purified proteins, foundational finding replicated across multiple labs","pmids":["2164710"],"is_preprint":false},{"year":1991,"finding":"Rap1A is specifically activated (GTPase stimulated) by a dedicated Rap1-GAP purified from bovine brain (rap1GAP, 85–95 kDa); this GAP does not act on p21ras and is distinct from Ras-GAP, establishing a separate regulatory circuit for Rap1A.","method":"Biochemical purification from bovine brain, cDNA cloning, expression in Sf9 cells, in vitro GTPase stimulation assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — protein purified to homogeneity, cDNA cloned and expressed, in vitro GTPase assay with specificity controls","pmids":["1904317"],"is_preprint":false},{"year":1991,"finding":"Rap1A is geranylgeranylated (C20 isoprenoid) at its COOH terminus in insect cells, in contrast to H-Ras which carries a farnesyl (C15) group, indicating that Rap1A is modified by a prenyl transferase distinct from farnesyl transferase; this COOH-terminal modification is required for membrane association.","method":"[3H]mevalonate labeling, baculovirus/Sf9 expression, SDS-PAGE, biochemical characterization of prenyl group","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct radiolabel incorporation with biochemical identification of lipid group, replicated and foundational","pmids":["1899909"],"is_preprint":false},{"year":1991,"finding":"Rap1A associates stoichiometrically with cytochrome b558 (the membrane component of the NADPH oxidase system) in human neutrophils; GTP-bound Rap1A binds more tightly than GDP-bound form; phosphorylation of Rap1A by cAMP-dependent protein kinase (PKA) inhibits this binding.","method":"Biochemical co-purification, GTP-γS binding, in vitro PKA phosphorylation, binding assay with purified components","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — stoichiometric complex formation with purified proteins, nucleotide-dependence and phosphorylation effect directly tested","pmids":["1763330"],"is_preprint":false},{"year":1991,"finding":"Rap1A is phosphorylated by cAMP-dependent protein kinase (PKA) on serine-180 in human neutrophils; this was established by amino acid sequence analysis of the purified protein, immunoprecipitation with a Rap1A-specific antibody, and mutagenesis of Ser-180.","method":"Electroporated neutrophils, [γ-32P]ATP labeling, immunoprecipitation, amino acid sequencing, carboxypeptidase digestion, site-directed mutagenesis (S180 mutant)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis confirming phosphorylation site, combined with protein purification and sequencing","pmids":["1908879"],"is_preprint":false},{"year":1990,"finding":"Ras-Krev-1 chimera studies mapped the transformation-suppressing activity of Krev-1/Rap1A to a small cluster of amino acids immediately surrounding the effector domain (residues 32–44), suggesting Krev-1 suppresses Ras transformation by competing for Ras effector interactions.","method":"Chimeric protein construction, NIH 3T3 transformation assay, focus formation","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic domain-swap mutagenesis with functional transformation readout, replicated concept","pmids":["2115210"],"is_preprint":false},{"year":1991,"finding":"A recombinant Rap1A with a Thr35→Ala mutation is unresponsive to Rap-GAP stimulation of GTPase activity, whereas wild-type Rap1A is activated by cytosolic Rap-GAP but not by Ras-GAP, demonstrating that the effector domain mediates GAP specificity.","method":"Baculovirus expression, in vitro GTPase assay, site-directed mutagenesis (T35A)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutant protein, clear mechanistic dissection of GAP specificity","pmids":["2160589"],"is_preprint":false},{"year":1996,"finding":"Rap1A binds the Ras-binding domain of Ral-GEF (RGF-RBD) with high affinity (KD ~low nM range vs. ~1 µM for H-Ras), while H-Ras binds Raf-RBD with high affinity; binding of RGF-RBD to Rap1A is blocked by the D38A effector mutation and inhibits Rap-GAP interaction, indicating RalGEF is an effector of Rap1A rather than H-Ras.","method":"In vitro binding assay (guanine nucleotide dissociation inhibition), deletion mapping, mutagenesis (D38A), quantitative KD measurements","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative in vitro binding with mutagenesis controls, mechanistic specificity established","pmids":["8636102"],"is_preprint":false},{"year":1997,"finding":"Rap1A/Krev-1 binds strongly to a novel ankyrin repeat protein KRIT1 in a yeast two-hybrid screen; KRIT1 interacted with Krev-1 but only weakly with Ras, suggesting it is a specific Krev-1 effector. KRIT1 maps to 7q21-22 and is later identified as the CCM1 gene.","method":"Yeast two-hybrid screen of HeLa cDNA library, domain mapping","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — yeast two-hybrid identification replicated by independent CCM1 cloning paper","pmids":["9285558"],"is_preprint":false},{"year":1999,"finding":"Mutations in KRIT1, the Krev-1/Rap1A-binding protein identified by two-hybrid, cause cerebral cavernous malformations (CCM1), establishing a direct link between the Rap1A signaling pathway and cerebrovascular disease/angiogenesis.","method":"Positional cloning, mutation identification in 23 CCM1 families, yeast two-hybrid confirmation of KRIT1-Rap1A interaction","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and biochemical evidence linking Rap1A pathway to cerebrovascular disease, though interaction itself tested by two-hybrid","pmids":["10545614"],"is_preprint":false},{"year":1991,"finding":"Rap1A proteins are localized to the Golgi complex in mammalian cells; they do not colocalize with Ras proteins on the plasma membrane; this localization is conferred by the C-terminal CAAX region and is distinct from Ras.","method":"Indirect immunofluorescence (anti-Rap1 peptide antibodies), subcellular fractionation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — immunofluorescence and fractionation, replicated in subsequent studies","pmids":["1900364"],"is_preprint":false},{"year":1994,"finding":"Rap1A and Rap1B proteins localize to late endocytic compartments (late endosomes/lysosomes) in fibroblasts, and also associate with phagosomes in macrophages, implicating Rap1A in late endocytic/phagocytic processes.","method":"Confocal immunofluorescence microscopy, subcellular fractionation, vaccinia T7 overexpression system","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — confocal microscopy and fractionation, two independent methods, single lab","pmids":["7962206"],"is_preprint":false},{"year":1992,"finding":"Rap1A colocalizes with cytochrome b558 in plasma membrane and specific granule membranes of resting neutrophils; upon PMA stimulation, Rap1A cotranslocates with cytochrome b to the plasma membrane and to phagolysosomal membranes during phagocytosis.","method":"Subcellular fractionation, Western blotting, immunoelectron microscopy (double-labeling), quantitative ultrastructural analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (fractionation, immunoEM, quantitative colocalization), colocalization directly tied to functional NADPH oxidase assembly","pmids":["1312373"],"is_preprint":false},{"year":1997,"finding":"Rap1A binds the cysteine-rich region (CRR, residues 152-184) of Raf-1 with greatly enhanced affinity compared to Ha-Ras; this leads to co-association of Rap1A and Ha-Ras with Raf-1 N-terminus through CRR and RBD respectively, and Rap1A thereby interferes with Ras-dependent Raf-1 activation.","method":"In vitro binding assay, Sf9 baculovirus co-expression, Raf-1 kinase activation assay, mutagenesis (N26G, V45E, E31K)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro binding and functional kinase assay with mutagenesis, single lab but multiple methods","pmids":["9115221"],"is_preprint":false},{"year":1999,"finding":"PKA phosphorylation of Rap1A at Ser-180 abolishes its binding to the Raf-1 cysteine-rich region (CRR) and prevents Rap1A from suppressing Ras-dependent Raf-1 activation; a phosphomimetic mutant S180E recapitulates this loss of suppressive function in COS-7 cells.","method":"In vitro binding assay, site-directed mutagenesis (S180E phosphomimetic), COS-7 cell co-transfection, Raf-1 kinase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphomimetic mutagenesis combined with in vitro binding and cellular functional assay","pmids":["9867809"],"is_preprint":false},{"year":2000,"finding":"AF-6 (afadin) binds Rap1A through its first Ras-binding domain more efficiently than oncogenic Ha-, K-, or N-Ras; Rap1A and Ras both interact with full-length AF-6 in mammalian cells and a fraction of Rap1A colocalizes with AF-6 at the membrane; AF-6 also associates with the actin regulator profilin.","method":"In vitro binding assay, co-immunoprecipitation in mammalian cells, immunofluorescence colocalization, MDCK and MCF-7 cell dominant-active Rap1A expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and in vitro binding, single lab, multiple methods","pmids":["10922060"],"is_preprint":false},{"year":2002,"finding":"Constitutively active Rap1A in transgenic T cells does not antagonize Ras signaling or induce T cell anergy; instead, it enhances TCR-mediated responses and induces strong activation of β1 and β2 integrins via an avidity-modulation mechanism in vivo.","method":"Transgenic mouse model (constitutively active Rap1A in T cell lineage), T cell activation assays, integrin activation/adhesion assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic mouse model with multiple functional readouts, overturned previous model","pmids":["11836528"],"is_preprint":false},{"year":2006,"finding":"Genetic deletion of Rap1A in mice causes impaired integrin-mediated adhesion of primary T and B cells to ICAM and fibronectin substrates, and impaired polarization of T cells after CD3 stimulation, confirming a role for Rap1A in integrin regulation in vivo.","method":"Homologous recombination knockout mouse, adhesion assays on ICAM/fibronectin, T cell polarization assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with defined cellular adhesion phenotype","pmids":["16382154"],"is_preprint":false},{"year":2007,"finding":"Rap1a-null mice show increased macrophage haptotaxis with decreased adhesion on fibronectin/vitronectin, reduced chemotaxis of lymphoid and myeloid cells to CXCL12/CCL21, increased FcR-mediated phagocytosis, and reduced fMLP-stimulated superoxide production in neutrophils, demonstrating non-redundant roles of Rap1a vs Rap1b.","method":"Rap1a gene deletion, macrophage haptotaxis/adhesion assays, chemotaxis assays, phagocytosis assay, superoxide production measurement","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with multiple defined cellular phenotypes, isoform-specific effects established","pmids":["18056377"],"is_preprint":false},{"year":1999,"finding":"RAP1A GTP/GDP cycling controls intracellular location of late endocytic compartments and contributes to myogenic differentiation; GDP-bound RAP1A clusters with acidic perinuclear structures and causes disturbances in cathepsin D maturation, while GTP-bound form inhibits and GDP-bound form promotes myotube formation.","method":"Stable cell lines expressing wild-type or mutant RAP1A, immunofluorescence, cathepsin D maturation assay, myogenic differentiation assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GTP/GDP mutants with multiple functional readouts, single lab","pmids":["9882515"],"is_preprint":false},{"year":2009,"finding":"JAM-A forms a complex with Afadin and PDZ-GEF2 to activate Rap1A, which in turn regulates β1 integrin protein levels and epithelial cell migration; knockdown of Rap1A (but not Rap1B) specifically decreased β1 integrin levels and reduced cell migration.","method":"Co-immunoprecipitation, siRNA knockdown of Rap1A vs Rap1B, β1 integrin quantification, cell migration assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, isoform-specific siRNA knockdown with defined phenotypic readouts, single lab","pmids":["19176753"],"is_preprint":false},{"year":2008,"finding":"Rap1a is required for FGF2-induced angiogenesis: rap1a−/− mice lack blood vessel growth into FGF2-containing Matrigel plugs and aortic rings fail to sprout; Rap1a/b knockdown in endothelial cells reduces adhesion, migration, tubular structure formation, and FGF2-induced ERK, p38, and Rac activation.","method":"Rap1a knockout mouse, Matrigel plug assay, aortic ring sprouting assay, siRNA knockdown in HMVECs, endothelial cell functional assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout combined with in vitro siRNA and multiple functional/signaling readouts","pmids":["18625726"],"is_preprint":false},{"year":2011,"finding":"Rap1A is the predominant isoform for endothelial junction formation and barrier function; Rap1A knockdown (not Rap1B) increases monolayer gaps and permeability; Rap1A localizes more strongly to junctions than Rap1B and co-immunoprecipitates more strongly with AF-6.","method":"miRNA-based isoform-specific knockdown, electrical impedance sensing, VE-cadherin immunostaining, GFP-tagged Rap1A/1B localization, co-immunoprecipitation","journal":"Small GTPases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods distinguishing isoforms, single lab","pmids":["21776404"],"is_preprint":false},{"year":1999,"finding":"SHEP1, a novel SH2 domain-containing protein, directly couples activated EphB2 receptor to Rap1A and R-Ras (but not Ha-Ras or RalA) via its GEF-like domain, as demonstrated in a yeast two-hybrid screen and binding assays.","method":"Yeast two-hybrid screen, SH2 binding to phosphorylated EphB2, tyrosine phosphorylation of SHEP1 in cells expressing activated EphB2","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 / Weak — yeast two-hybrid identification with limited biochemical follow-up for Rap1A interaction","pmids":["10542222"],"is_preprint":false},{"year":1991,"finding":"Rap1A (both GDP and GTP-bound forms) competitively inhibits the ability of Ras-GAP to block M2-muscarinic receptor-coupled K+ channel activation; a T35A effector-domain mutation abolishes this antagonism, confirming that the effector domain mediates Rap1A competition with GAP.","method":"Electrophysiology patch clamp, addition of purified Rap1A proteins, T35A mutagenesis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro electrophysiology with purified proteins and mutagenesis, single lab","pmids":["1939245"],"is_preprint":false},{"year":1991,"finding":"Heterogeneous amino acids in Ras and Rap1A carboxyl-terminal to the effector region determine sensitivity to different GAPs: residues 61–65 of Ras confer Ras-GAP sensitivity, while a larger set of Rap1A residues mediates sensitivity to cytoplasmic Rap-GAP; sensitivity to membrane Rap-GAP requires yet other residues.","method":"Chimeric protein construction, in vitro GTPase assay with different GAPs, NIH 3T3 transformation assay","journal":"Science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic chimera mutagenesis with in vitro GTPase assays, single lab","pmids":["1749934"],"is_preprint":false},{"year":1992,"finding":"Purified recombinant Krev-1/Rap1A reconstitutes NADPH oxidase activity in immunodepleted neutrophil cytosol; H-Ras and yeast RAS proteins lack this activity; an antibody against the effector region (residues 31-43) of Krev-1 inhibits cell-free NADPH oxidase activation.","method":"Immunodepletion of cytosol, reconstitution with purified recombinant Krev-1, H-Ras controls, blocking antibody experiment","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution with specificity controls, single lab","pmids":["1906890"],"is_preprint":false},{"year":1992,"finding":"Dominant-negative (N17) and constitutively active (V12, GTPase-defective) mutants of Rap1A both inhibit superoxide production in differentiated HL60 cells, while overexpression of wild-type Rap1A increases O2−production fourfold, establishing that cycling between GDP- and GTP-bound forms is required for continuous NADPH oxidase activation.","method":"Stable transfection of HL60 cells with Rap1A mutants, differentiation to neutrophil-like cells, superoxide production assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple Rap1A mutants with functional NADPH oxidase assay, single lab","pmids":["7833480"],"is_preprint":false},{"year":2003,"finding":"Active GTP-bound Rap1A translocates to the nucleus in squamous cell carcinoma cells, whereas inactive GDP-bound Rap1A is retained in the cytoplasm; nuclear translocation is induced by growth factors, as demonstrated by GFP-tagged constitutively active and inactive forms.","method":"GFP-tagging of active/inactive Rap1A, immunofluorescence, subcellular fractionation, immunohistochemistry on human cancer specimens","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GFP-fusion imaging with GTP/GDP-state-dependent localization, supported by IHC","pmids":["13679863"],"is_preprint":false},{"year":2010,"finding":"Gβγ subunits of heterotrimeric G proteins form a complex with activated Rap1A and its effector Radil downstream of GPCR stimulation; Gβγ, activated Rap1A, and Radil promote translocation of Radil to the plasma membrane at sites of cell-matrix contact and are required for inside-out integrin activation.","method":"Co-immunoprecipitation, siRNA knockdown, integrin activation assay, live-cell imaging of Radil translocation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP of endogenous complex with functional siRNA knockdown, single lab","pmids":["20048162"],"is_preprint":false},{"year":2012,"finding":"KIF14 associates with the PDZ domain of the Rap1A effector Radil and tethers Radil on microtubules, negatively regulating Rap1A-mediated inside-out integrin activation; KIF14 depletion leads to increased cell spreading and altered focal adhesion dynamics.","method":"Co-immunoprecipitation, pulldown with PDZ domain, siRNA knockdown of KIF14, integrin activation assay, focal adhesion imaging, mouse xenograft","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical interaction mapping plus functional knockdown with cellular phenotype, single lab","pmids":["23209302"],"is_preprint":false},{"year":2013,"finding":"PI3Kγ activates PLCγ → CalDAG-GEFI/II → Rap1A → RIAM pathway to induce integrin α4β1-mediated extravasation of myeloid cells; genetic depletion of Rap1A (but not constitutively active RapV12 which bypasses upstream signals) was sufficient to prevent integrin α4 activation and suppress myeloid cell recruitment to tumors.","method":"Genetic deletion/siRNA of pathway components in mouse, integrin activation assay, in vivo tumor inflammation model, epistasis analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in vivo with multiple pathway knockouts, single lab","pmids":["23565202"],"is_preprint":false},{"year":2012,"finding":"cAMP-Epac2-Rap1A-RhoA signaling in microvascular smooth muscle cells induces translocation of α2C-adrenoceptors from the Golgi/perinuclear region to the cell surface; this effect is impaired in Rap1A-null mouse microVSM and rescued by constitutively active Rap1A.","method":"Pharmacological activation of Epac/cAMP, Rap1A-null mouse microVSM, constitutively active Rap1A rescue, α2C-AR localization imaging","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — null mouse rescue experiment with functional receptor localization readout, single lab","pmids":["22621783"],"is_preprint":false},{"year":2013,"finding":"cAMP-Rap1A signaling facilitates translocation of α2C-adrenoceptors to the cell surface via filamin-2; yeast two-hybrid identified filamin-2 as an α2C-AR binding partner; Rap1A stimulation caused α2C-ARs to colocalize with filamin-2 on intracellular filaments and at the plasma membrane; filamin-2 knockdown inhibited Rap1-induced receptor surface delivery.","method":"Yeast two-hybrid, co-immunoprecipitation, site-directed mutagenesis, siRNA knockdown of filamin-2, confocal imaging","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (Y2H, co-IP, mutagenesis, siRNA) but single lab","pmids":["23864608"],"is_preprint":false},{"year":2014,"finding":"Rap1A mediates thrombin (PAR-1)-stimulated glioblastoma cell adhesion to fibronectin and proliferation via a RhoA-PLD-Rap1A-β1 integrin pathway; siRNA knockdown of Rap1A (but not Rap1B) reduces tumor mass by >70% in mouse xenograft; Rap1A knockdown reduces phospho-FAK and phospho-ERK.","method":"siRNA knockdown of Rap1A vs Rap1B, cell adhesion assay, FAK/ERK phosphorylation, β1 integrin neutralization, mouse xenograft model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific siRNA, in vivo xenograft, multiple signaling readouts, single lab","pmids":["24790104"],"is_preprint":false},{"year":2011,"finding":"Rap1a activation by CalDAG-GEFI (Rasgrp2) and p38 MAPK (downstream of PLCγ2) is required for E-selectin-dependent slow leukocyte rolling and αLβ2 integrin activation; dominant-negative Rap1a blocked E-selectin-mediated slow rolling in Pik3cg−/− mice; Rasgrp2−/− mice lost E-selectin-dependent neutrophil recruitment.","method":"Intravital microscopy, Tat-fusion dominant-negative mutants, gene-deficient mice (Rasgrp2−/−, Pik3cg−/−), peritonitis model, biochemical studies","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with multiple knockout models and functional intravital imaging","pmids":["21480213"],"is_preprint":false},{"year":2018,"finding":"Rap1A is required for lymphatic development: conditional knockout of Rap1a/b in lymphatic endothelial cells causes embryonic lethality with interstitial edema, blood-filled lymphatics, disrupted lymphovenous valves, and defective lymphangiogenesis; Rap1A/B knockdown disrupts junctional formation and impairs adrenomedullin-induced junctional tightening.","method":"Conditional knockout mouse (two independent lines), siRNA knockdown in human lymphatic endothelial cells, permeability assay, immunofluorescence","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent conditional knockout mouse lines with defined developmental phenotype and in vitro junctional assays","pmids":["30354217"],"is_preprint":false},{"year":2020,"finding":"Rap1A allosterically activates phospholipase Cε (PLCε) by binding the RA2 domain; the PH domain and first two EF hands of PLCε are also required for Rap1A-mediated activation; hydrophobic residues on the RA2 surface are essential; SAXS shows Rap1A binding induces discrete conformational states in PLCε, providing the first structural evidence for allosteric activation.","method":"In vitro PLCε activity assay with purified proteins, mutagenesis (RA2 domain residues, PH, EF hands), small-angle X-ray scattering (SAXS), pulldown with purified proteins","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and structural (SAXS) validation, multiple orthogonal methods in one study","pmids":["32948655"],"is_preprint":false},{"year":2016,"finding":"Phosphorylation in the polybasic region (PBR) of Rap1A does not detectably inhibit its prenylation or binding to SmgGDS-607 (unlike Rap1B where S179/S180 phosphorylation inhibits these interactions); GPCR activation suppresses Rap1A prenylation but does not diminish Rap1A membrane localization, revealing isoform-specific regulation of prenylation.","method":"Binding assays (SmgGDS-607 interaction), mutagenesis of PBR residues, prenylation assays, GPCR stimulation experiments","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mutagenesis and binding assays, single lab, reveals mechanistic difference from Rap1B","pmids":["27760305"],"is_preprint":false},{"year":2022,"finding":"Hepatocyte Rap1A activation suppresses gluconeogenic gene expression and hepatic glucose production via induction of actin polymerization that leads to Akt-mediated FoxO1 inhibition; Rap1A activity depends on geranylgeranylation for membrane localization; statins reduce Rap1A activity and stimulate hepatic gluconeogenesis; geranylgeraniol treatment restores Rap1A activity.","method":"Rap1a silencing and overexpression in hepatocytes, glucose production assay, actin polymerization assay, Akt/FoxO1 phosphorylation, statin treatment, geranylgeraniol rescue, obese mouse model","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional and signaling assays with rescue experiments, single lab","pmids":["36001955"],"is_preprint":false},{"year":2024,"finding":"Rap1A knockdown in endothelial cells increases store-operated calcium entry (SOCE) through Orai1 channels, enhancing NFAT1 nuclear translocation and pro-inflammatory cytokine expression; EC-specific Rap1A knockout mice show inflammatory lung phenotype with increased permeability; siRNA-mediated Orai1 knockdown normalizes SOCE, NFAT activity, and barrier function in Rap1A-depleted cells and mice.","method":"siRNA knockdown of Rap1A vs Rap1B, whole-cell patch clamp (CRAC current), NFAT translocation assay, cytokine ELISA, EC-specific conditional Rap1A knockout mouse, lipid-nanoparticle siRNA delivery","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — electrophysiology, genetic knockout mouse, mechanistic rescue experiments, multiple orthogonal methods","pmids":["39324266"],"is_preprint":false},{"year":2022,"finding":"TRPM8 channel directly interacts with Rap1A via specific residues (E207 and Y240 on TRPM8; Y32 on Rap1A); this interaction traps Rap1A in GDP-bound inactive form and inhibits cell migration and adhesion in prostate cancer cells; point mutations at these sites disrupt PPI and abolish the functional effects.","method":"Active Rap1 pull-down assay, GST-pulldown, co-immunoprecipitation, proximity ligation assay (PLA), molecular modeling, site-directed mutagenesis, live-cell imaging, migration/adhesion assays","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple interaction methods plus mutagenesis and functional assays, single lab","pmids":["35565390"],"is_preprint":false},{"year":1992,"finding":"The C-terminal geranylgeranylated region of Rap1A/Krev-1 is essential for interaction with smg GDS (guanine nucleotide exchange factor); mapping by cross-linking identified residues 444-492 of smg GDS as the domain interacting with the C-terminal region of Rap1A; deletion of these residues abolishes GDS activity on Rap1A.","method":"Cross-linking, site-directed mutagenesis/deletion of smg GDS, GDS exchange activity assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — cross-linking and mutagenesis defining interaction domain, in vitro biochemical assay, single lab","pmids":["1501882"],"is_preprint":false}],"current_model":"RAP1A is a Ras-family small GTPase that is geranylgeranylated at its C-terminus for membrane localization, cycles between GDP- and GTP-bound states regulated by dedicated GAPs (rap1GAP) and GEFs (CalDAG-GEFI, Epac/smgGDS), and acts as a signaling hub that: (1) competes with Ras for GAP binding to suppress Ras-driven transformation; (2) activates integrins (β1, β2, α4β1, αLβ2) via effectors including RIAM and Radil to control cell adhesion, migration, and leukocyte trafficking; (3) is phosphorylated by PKA at Ser-180, which abolishes its binding to the Raf-1 cysteine-rich region and its Ras-suppressive function; (4) associates with cytochrome b558 of the NADPH oxidase to regulate superoxide production in phagocytes; (5) allosterically activates PLCε through its RA2 domain; (6) regulates endothelial junctions and lymphatic development; and (7) controls hepatic gluconeogenesis via actin polymerization and Akt/FoxO1 signaling."},"narrative":{"mechanistic_narrative":"RAP1A is a Ras-family small GTPase that cycles between GDP- and GTP-bound states to act as a signaling hub for cell adhesion, integrin activation, and vascular morphogenesis [PMID:11836528, PMID:16382154]. It is geranylgeranylated at its C-terminus, a modification distinct from the farnesylation of H-Ras that is required for membrane association and downstream activity, and which depends on smgGDS engagement of its C-terminal polybasic region [PMID:1899909, PMID:1501882, PMID:36001955]. RAP1A nucleotide cycling is governed by a dedicated regulatory circuit: a Rap1-specific GAP that stimulates its GTPase but does not act on Ras, with GAP specificity dictated by effector-domain residues including Thr35 [PMID:1904317, PMID:2160589]. Structurally, GTP-loaded RAP1A engages effector Ras-binding domains through an antiparallel beta-sheet between its switch I region and the effector, the basis of its overlapping yet distinct effector repertoire relative to Ras [PMID:7791872]. RAP1A binds tightly to Ras-GAP and to the Raf-1 cysteine-rich region, thereby competitively antagonizing Ras-driven Raf-1 activation and transformation; PKA phosphorylation at Ser-180 abolishes Raf-1 CRR binding and abrogates this suppressive function [PMID:2164710, PMID:9115221, PMID:9867809, PMID:2115210]. Beyond Ras antagonism, RAP1A selectively engages effectors such as RalGEF, KRIT1, and AF-6/afadin [PMID:8636102, PMID:9285558, PMID:10922060]. In leukocytes it drives inside-out activation of β1, β2, α4β1, and αLβ2 integrins through CalDAG-GEFI and effectors RIAM and Radil to control adhesion, polarization, chemotaxis, and selectin-dependent rolling [PMID:11836528, PMID:16382154, PMID:23565202, PMID:21480213, PMID:20048162]. RAP1A associates with cytochrome b558 of the NADPH oxidase and supports phagocyte superoxide production through GDP/GTP cycling [PMID:1763330, PMID:1312373, PMID:1906890, PMID:7833480]. In the endothelium and lymphatics it is the predominant isoform for junctional integrity and barrier function, is required for FGF2-induced angiogenesis and lymphatic development, and restrains store-operated calcium entry through Orai1 to limit inflammatory signaling [PMID:21776404, PMID:18625726, PMID:30354217, PMID:39324266]. Mutations in the RAP1A-binding effector KRIT1 cause cerebral cavernous malformations, linking this pathway to cerebrovascular disease [PMID:10545614].","teleology":[{"year":1990,"claim":"Establishing how Krev-1/Rap1A suppresses Ras transformation showed it acts by competing for Ras regulatory and effector interactions rather than by enzymatic activation.","evidence":"in vitro GTPase/competitive inhibition with purified proteins, plus Ras-Krev-1 chimera transformation assays in NIH 3T3 cells","pmids":["2164710","2115210"],"confidence":"High","gaps":["Did not identify the dedicated GAP/GEF circuit","Did not establish the physiological effectors mediating suppression"]},{"year":1991,"claim":"Defining Rap1A's distinct regulatory and processing machinery established it as an autonomous GTPase circuit separate from Ras.","evidence":"purification of a Rap1-specific GAP from bovine brain, geranylgeranylation identified by mevalonate labeling, T35A mutant showing effector-domain control of GAP specificity, and chimera mapping of GAP-sensitivity residues","pmids":["1904317","1899909","2160589","1749934"],"confidence":"High","gaps":["GEFs activating Rap1A in vivo not yet defined","Physiological output of the cycle not established"]},{"year":1991,"claim":"Identifying Ser-180 as the PKA phosphorylation site and the cytochrome b558 association provided the first regulated functional readouts of Rap1A in phagocytes.","evidence":"32P-labeling, sequencing and S180 mutagenesis in neutrophils; stoichiometric co-purification with cytochrome b558 and nucleotide/phosphorylation-dependent binding; Golgi localization by immunofluorescence","pmids":["1908879","1763330","1900364"],"confidence":"High","gaps":["Functional consequence of Ser-180 phosphorylation not yet mapped to a specific effector","Mechanism coupling Rap1A to oxidase assembly unresolved"]},{"year":1992,"claim":"Reconstitution and mutant studies established that Rap1A GDP/GTP cycling is functionally required for NADPH oxidase activation, not merely correlated with it.","evidence":"reconstitution of immunodepleted neutrophil cytosol with recombinant Krev-1, blocking-antibody experiments, dominant-negative/constitutively-active Rap1A in HL60 cells, and immunoEM cotranslocation with cytochrome b","pmids":["1906890","7833480","1312373"],"confidence":"Medium","gaps":["GEF/GAP controlling oxidase-linked cycling not identified","Direct catalytic contribution of Rap1A to electron transfer unresolved"]},{"year":1996,"claim":"Quantitative effector binding distinguished the Rap1A and Ras effector repertoires, showing RalGEF binds Rap1A preferentially while Raf binds Ras.","evidence":"in vitro nucleotide-dissociation binding assays with KD measurements and D38A effector mutant","pmids":["8636102"],"confidence":"High","gaps":["Cellular consequences of Rap1A-RalGEF engagement not addressed","In vivo relevance of effector partitioning not tested"]},{"year":1997,"claim":"Mapping Rap1A binding to the Raf-1 cysteine-rich region provided a structural mechanism for Ras antagonism, refined by the Rap1A-Raf RBD crystal structure.","evidence":"in vitro binding and Raf-1 kinase activation assays with mutagenesis; 2.2 Å crystal structure of GppNHp-Rap1A with Raf RBD","pmids":["9115221","7791872"],"confidence":"High","gaps":["Whether CRR binding occurs at endogenous protein levels not shown","Structural basis of full-length Raf engagement incomplete"]},{"year":1999,"claim":"PKA phosphorylation at Ser-180 was shown to abolish Raf-1 CRR binding and Ras-suppressive function, linking cAMP signaling to control of Rap1A's anti-Ras activity.","evidence":"in vitro binding and S180E phosphomimetic mutant with Raf-1 kinase assay in COS-7 cells","pmids":["9867809"],"confidence":"High","gaps":["In vivo kinetics of Ser-180 phosphorylation not quantified","Effect on other Rap1A effectors not examined"]},{"year":1999,"claim":"Two-hybrid and positional cloning identified KRIT1 as a specific Rap1A effector and tied the pathway to cerebral cavernous malformations.","evidence":"yeast two-hybrid screen and positional cloning with mutation identification in CCM1 families","pmids":["9285558","10545614"],"confidence":"Medium","gaps":["Interaction validated mainly by two-hybrid","Mechanism by which Rap1A-KRIT1 signaling prevents malformations not established"]},{"year":2002,"claim":"Transgenic and knockout mouse studies reframed Rap1A's principal in vivo role from Ras antagonist to integrin activator controlling lymphocyte adhesion and polarization.","evidence":"constitutively active Rap1A transgenic T cells and homologous-recombination Rap1A knockout with adhesion and polarization assays","pmids":["11836528","16382154"],"confidence":"High","gaps":["Effectors linking Rap1A to integrins not fully defined in these studies","Distinction from Rap1B not yet addressed"]},{"year":2007,"claim":"Clean Rap1a knockout established non-redundant, isoform-specific roles in myeloid/lymphoid adhesion, chemotaxis, phagocytosis, and superoxide production.","evidence":"Rap1a gene deletion with haptotaxis, chemotaxis, phagocytosis, and superoxide assays","pmids":["18056377"],"confidence":"High","gaps":["Molecular basis of opposing adhesion/haptotaxis phenotypes unresolved","Compensation by Rap1b not fully delineated"]},{"year":2013,"claim":"Defining the upstream GEF cascades and effector adaptors clarified how Rap1A converts receptor signals into integrin activation during leukocyte trafficking.","evidence":"Gβγ-Rap1A-Radil complex co-IP and translocation imaging; CalDAG-GEFI/p38 epistasis in knockout mice with intravital microscopy; PI3Kγ-CalDAG-GEFI-RIAM epistasis in tumor recruitment models; KIF14-Radil tethering studies","pmids":["20048162","21480213","23565202","23209302"],"confidence":"Medium","gaps":["Relative contributions of distinct GEFs in different cell types unresolved","Structural basis of Radil/RIAM recruitment not defined"]},{"year":2018,"claim":"Vascular and lymphatic genetic models established Rap1A as the predominant isoform for endothelial junction integrity, angiogenesis, and lymphatic development.","evidence":"FGF2 Matrigel/aortic-ring assays in Rap1a knockouts; isoform-specific knockdown with impedance and VE-cadherin imaging; conditional lymphatic-EC knockout with developmental phenotyping","pmids":["18625726","21776404","30354217"],"confidence":"High","gaps":["Junctional effector(s) downstream of Rap1A only partly defined (AF-6)","Mechanism distinguishing Rap1A from Rap1B at junctions incompletely resolved"]},{"year":2020,"claim":"Structural and biochemical work defined how Rap1A allosterically activates PLCε, identifying a new direct effector mechanism.","evidence":"in vitro PLCε activity assays with RA2/PH/EF-hand mutagenesis and SAXS conformational analysis","pmids":["32948655"],"confidence":"High","gaps":["High-resolution structure of the active complex lacking","Cellular signaling consequences of PLCε activation by Rap1A not mapped"]},{"year":2024,"claim":"Recent work expanded Rap1A's endothelial role to restraint of store-operated calcium entry and metabolic control of hepatic gluconeogenesis.","evidence":"EC-specific Rap1A knockout with patch-clamp CRAC current, Orai1 rescue, and NFAT assays; hepatocyte Rap1a silencing/overexpression with glucose production, actin polymerization, Akt/FoxO1 readouts and statin/geranylgeraniol rescue","pmids":["39324266","36001955"],"confidence":"Medium","gaps":["Molecular link between Rap1A and Orai1 regulation not defined","Effectors mediating actin-dependent Akt/FoxO1 control in hepatocytes unidentified"]},{"year":null,"claim":"How the dozens of Rap1A effectors and isoform-specific functions are coordinated and spatially partitioned across cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified map of effector selection across tissues","GEF/GAP determinants of context-specific Rap1A versus Rap1B output unknown","Structures of Rap1A bound to integrin-activation effectors (RIAM/Radil) lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,2,7]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[17,18,30]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,14,38]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[11,33]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13,23,30]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[12,20]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[29]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,30,36]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[18,19,32,36]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[22,37]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[18,35]}],"complexes":["NADPH oxidase (cytochrome b558 complex)"],"partners":["RAF1","KRIT1","MLLT4","RALGDS","RASA1","RAP1GAP","PLCE1","RADIL"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P62834","full_name":"Ras-related protein Rap-1A","aliases":["C21KG","G-22K","GTP-binding protein smg p21A","Ras-related protein Krev-1"],"length_aa":184,"mass_kda":21.0,"function":"Counteracts the mitogenic function of Ras, at least partly because it can interact with Ras GAPs and RAF in a competitive manner. Together with ITGB1BP1, regulates KRIT1 localization to microtubules and membranes (PubMed:17916086). Plays a role in nerve growth factor (NGF)-induced neurite outgrowth. Plays a role in the regulation of embryonic blood vessel formation. Involved in the establishment of basal endothelial barrier function. Facilitates the progressive accumulation of CDH1 at mature desmosome junctions via cAMP-dependent signaling and its interaction with PKP3 (PubMed:25208567). May be involved in the regulation of the vascular endothelial growth factor receptor KDR expression at endothelial cell-cell junctions","subcellular_location":"Cell membrane; Cytoplasm; Cytoplasm, perinuclear region; Cell junction; Early endosome","url":"https://www.uniprot.org/uniprotkb/P62834/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAP1A","classification":"Not Classified","n_dependent_lines":31,"n_total_lines":1208,"dependency_fraction":0.02566225165562914},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RAP1A","total_profiled":1310},"omim":[{"mim_id":"620408","title":"MICRO RNA 337; MIR337","url":"https://www.omim.org/entry/620408"},{"mim_id":"616743","title":"RAL GUANINE NUCLEOTIDE DISSOCIATION STIMULATOR-LIKE 3; RGL3","url":"https://www.omim.org/entry/616743"},{"mim_id":"614532","title":"RASGEF DOMAIN FAMILY, MEMBER 1B; RASGEF1B","url":"https://www.omim.org/entry/614532"},{"mim_id":"614531","title":"RASGEF DOMAIN FAMILY, MEMBER 1A; RASGEF1A","url":"https://www.omim.org/entry/614531"},{"mim_id":"611491","title":"RAS ASSOCIATION AND DILUTE DOMAINS PROTEIN; RADIL","url":"https://www.omim.org/entry/611491"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAP1A"},"hgnc":{"alias_symbol":["KREV-1","SMGP21"],"prev_symbol":[]},"alphafold":{"accession":"P62834","domains":[{"cath_id":"3.40.50.300","chopping":"1-167","consensus_level":"high","plddt":95.1624,"start":1,"end":167}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P62834","model_url":"https://alphafold.ebi.ac.uk/files/AF-P62834-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P62834-F1-predicted_aligned_error_v6.png","plddt_mean":92.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAP1A","jax_strain_url":"https://www.jax.org/strain/search?query=RAP1A"},"sequence":{"accession":"P62834","fasta_url":"https://rest.uniprot.org/uniprotkb/P62834.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P62834/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P62834"}},"corpus_meta":[{"pmid":"7791872","id":"PMC_7791872","title":"The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7791872","citation_count":510,"is_preprint":false},{"pmid":"8636102","id":"PMC_8636102","title":"Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8636102","citation_count":311,"is_preprint":false},{"pmid":"10545614","id":"PMC_10545614","title":"Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10545614","citation_count":304,"is_preprint":false},{"pmid":"2164710","id":"PMC_2164710","title":"Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product.","date":"1990","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2164710","citation_count":254,"is_preprint":false},{"pmid":"1904317","id":"PMC_1904317","title":"Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1904317","citation_count":244,"is_preprint":false},{"pmid":"11836528","id":"PMC_11836528","title":"Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling.","date":"2002","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11836528","citation_count":234,"is_preprint":false},{"pmid":"9285558","id":"PMC_9285558","title":"Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9285558","citation_count":180,"is_preprint":false},{"pmid":"10922060","id":"PMC_10922060","title":"The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10922060","citation_count":170,"is_preprint":false},{"pmid":"7962206","id":"PMC_7962206","title":"Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complex.","date":"1994","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/7962206","citation_count":148,"is_preprint":false},{"pmid":"19176753","id":"PMC_19176753","title":"Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration.","date":"2009","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/19176753","citation_count":146,"is_preprint":false},{"pmid":"1900364","id":"PMC_1900364","title":"Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1900364","citation_count":138,"is_preprint":false},{"pmid":"1908879","id":"PMC_1908879","title":"Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1908879","citation_count":111,"is_preprint":false},{"pmid":"2115210","id":"PMC_2115210","title":"Identification of small clusters of divergent amino acids that mediate the opposing effects of ras and Krev-1.","date":"1990","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2115210","citation_count":105,"is_preprint":false},{"pmid":"1321333","id":"PMC_1321333","title":"Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1321333","citation_count":104,"is_preprint":false},{"pmid":"1763330","id":"PMC_1763330","title":"Inhibition of Rap1A binding to cytochrome b558 of NADPH oxidase by phosphorylation of Rap1A.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1763330","citation_count":104,"is_preprint":false},{"pmid":"1899909","id":"PMC_1899909","title":"The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.","date":"1991","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1899909","citation_count":103,"is_preprint":false},{"pmid":"16382154","id":"PMC_16382154","title":"Rap1A-deficient T and B cells show impaired integrin-mediated cell adhesion.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16382154","citation_count":100,"is_preprint":false},{"pmid":"18056377","id":"PMC_18056377","title":"Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18056377","citation_count":98,"is_preprint":false},{"pmid":"1846040","id":"PMC_1846040","title":"Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1846040","citation_count":95,"is_preprint":false},{"pmid":"22723956","id":"PMC_22723956","title":"miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22723956","citation_count":94,"is_preprint":false},{"pmid":"10542222","id":"PMC_10542222","title":"A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10542222","citation_count":94,"is_preprint":false},{"pmid":"7833480","id":"PMC_7833480","title":"Function of wild-type or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation.","date":"1995","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7833480","citation_count":90,"is_preprint":false},{"pmid":"9115221","id":"PMC_9115221","title":"Coassociation of Rap1A and Ha-Ras with Raf-1 N-terminal region interferes with ras-dependent activation of Raf-1.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115221","citation_count":90,"is_preprint":false},{"pmid":"18625726","id":"PMC_18625726","title":"Rap1a is a key regulator of fibroblast growth factor 2-induced angiogenesis and together with Rap1b controls human endothelial cell functions.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18625726","citation_count":89,"is_preprint":false},{"pmid":"1732742","id":"PMC_1732742","title":"RSR1, a ras-like gene homologous to Krev-1 (smg21A/rap1A): role in the development of cell polarity and interactions with the Ras pathway in Saccharomyces cerevisiae.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1732742","citation_count":86,"is_preprint":false},{"pmid":"8034626","id":"PMC_8034626","title":"Activated or dominant inhibitory mutants of Rap1A decrease the oxidative burst of Epstein-Barr virus-transformed human B lymphocytes.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8034626","citation_count":80,"is_preprint":false},{"pmid":"21480213","id":"PMC_21480213","title":"Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21480213","citation_count":79,"is_preprint":false},{"pmid":"2111441","id":"PMC_2111441","title":"Tissue and subcellular distributions of the smg-21/rap1/Krev-1 proteins which are partly distinct from those of c-ras p21s.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2111441","citation_count":76,"is_preprint":false},{"pmid":"1312373","id":"PMC_1312373","title":"Subcellular distribution of the Rap1A protein in human neutrophils: colocalization and cotranslocation with cytochrome b559.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1312373","citation_count":74,"is_preprint":false},{"pmid":"11788600","id":"PMC_11788600","title":"Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11788600","citation_count":74,"is_preprint":false},{"pmid":"1906890","id":"PMC_1906890","title":"Resolution of a low molecular weight G protein in neutrophil cytosol required for NADPH oxidase activation and reconstitution by recombinant Krev-1 protein.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1906890","citation_count":69,"is_preprint":false},{"pmid":"1323817","id":"PMC_1323817","title":"smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1323817","citation_count":68,"is_preprint":false},{"pmid":"13679863","id":"PMC_13679863","title":"Rap1A and rap1B ras-family proteins are prominently expressed in the nucleus of squamous carcinomas: nuclear translocation of GTP-bound active form.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/13679863","citation_count":68,"is_preprint":false},{"pmid":"23209302","id":"PMC_23209302","title":"KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23209302","citation_count":67,"is_preprint":false},{"pmid":"22859270","id":"PMC_22859270","title":"MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.","date":"2012","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22859270","citation_count":65,"is_preprint":false},{"pmid":"25636908","id":"PMC_25636908","title":"MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.","date":"2015","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/25636908","citation_count":64,"is_preprint":false},{"pmid":"27925454","id":"PMC_27925454","title":"Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling.","date":"2016","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27925454","citation_count":64,"is_preprint":false},{"pmid":"21776404","id":"PMC_21776404","title":"Isoform-specific differences between Rap1A and Rap1B GTPases in the formation of endothelial cell junctions.","date":"2011","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/21776404","citation_count":64,"is_preprint":false},{"pmid":"2507536","id":"PMC_2507536","title":"Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2507536","citation_count":60,"is_preprint":false},{"pmid":"29904277","id":"PMC_29904277","title":"miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a.","date":"2018","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29904277","citation_count":59,"is_preprint":false},{"pmid":"20964430","id":"PMC_20964430","title":"Vibrational Stark effect spectroscopy at the interface of Ras and Rap1A bound to the Ras binding domain of RalGDS reveals an electrostatic mechanism for protein-protein interaction.","date":"2010","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/20964430","citation_count":58,"is_preprint":false},{"pmid":"23565202","id":"PMC_23565202","title":"PI3-kinase γ promotes Rap1a-mediated activation of myeloid cell integrin α4β1, leading to tumor inflammation and growth.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23565202","citation_count":56,"is_preprint":false},{"pmid":"9867809","id":"PMC_9867809","title":"Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9867809","citation_count":52,"is_preprint":false},{"pmid":"2160589","id":"PMC_2160589","title":"Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins.","date":"1990","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2160589","citation_count":51,"is_preprint":false},{"pmid":"24790104","id":"PMC_24790104","title":"The Ras-related protein, Rap1A, mediates thrombin-stimulated, integrin-dependent glioblastoma cell proliferation and tumor growth.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24790104","citation_count":51,"is_preprint":false},{"pmid":"22621783","id":"PMC_22621783","title":"Cyclic AMP-Rap1A signaling activates RhoA to induce α(2c)-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22621783","citation_count":51,"is_preprint":false},{"pmid":"28232663","id":"PMC_28232663","title":"cAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells.","date":"2017","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28232663","citation_count":46,"is_preprint":false},{"pmid":"26599016","id":"PMC_26599016","title":"Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26599016","citation_count":43,"is_preprint":false},{"pmid":"20048162","id":"PMC_20048162","title":"G protein betagamma subunits regulate cell adhesion through Rap1a and its effector Radil.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20048162","citation_count":41,"is_preprint":false},{"pmid":"11850806","id":"PMC_11850806","title":"Role of cAMP, PKA and Rap1A in thyroid follicular cell survival.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11850806","citation_count":41,"is_preprint":false},{"pmid":"34725437","id":"PMC_34725437","title":"FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE-/- mice atherosclerosis.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34725437","citation_count":38,"is_preprint":false},{"pmid":"1380149","id":"PMC_1380149","title":"Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1380149","citation_count":36,"is_preprint":false},{"pmid":"24451631","id":"PMC_24451631","title":"MiR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells.","date":"2015","source":"The Clinical journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/24451631","citation_count":35,"is_preprint":false},{"pmid":"1749934","id":"PMC_1749934","title":"Heterogeneous amino acids in Ras and Rap1A specifying sensitivity to GAP proteins.","date":"1991","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1749934","citation_count":34,"is_preprint":false},{"pmid":"2108841","id":"PMC_2108841","title":"Chromosome mapping of the human RAS-related RAP1A, RAP1B, and RAP2 genes to chromosomes 1p12----p13, 12q14, and 13q34, respectively.","date":"1990","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2108841","citation_count":34,"is_preprint":false},{"pmid":"1628649","id":"PMC_1628649","title":"Generation of specific antibodies against the rap1A, rap1B and rap2 small GTP-binding proteins. Analysis of rap and ras proteins in membranes from mammalian cells.","date":"1992","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1628649","citation_count":33,"is_preprint":false},{"pmid":"1939245","id":"PMC_1939245","title":"Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1939245","citation_count":33,"is_preprint":false},{"pmid":"31047726","id":"PMC_31047726","title":"miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.","date":"2019","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/31047726","citation_count":31,"is_preprint":false},{"pmid":"11146560","id":"PMC_11146560","title":"Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11146560","citation_count":30,"is_preprint":false},{"pmid":"23864608","id":"PMC_23864608","title":"Cyclic AMP-Rap1A signaling mediates cell surface translocation of microvascular smooth muscle α2C-adrenoceptors through the actin-binding protein filamin-2.","date":"2013","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23864608","citation_count":28,"is_preprint":false},{"pmid":"33332780","id":"PMC_33332780","title":"miR-590-3p Alleviates diabetic peripheral neuropathic pain by targeting RAP1A and suppressing infiltration by the T cells.","date":"2020","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/33332780","citation_count":28,"is_preprint":false},{"pmid":"27760305","id":"PMC_27760305","title":"Differences in the Phosphorylation-Dependent Regulation of Prenylation of Rap1A and Rap1B.","date":"2016","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27760305","citation_count":27,"is_preprint":false},{"pmid":"15064832","id":"PMC_15064832","title":"Expression and significance of Rap1A in testes of azoospermic subjects.","date":"2004","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/15064832","citation_count":24,"is_preprint":false},{"pmid":"30883336","id":"PMC_30883336","title":"Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.","date":"2019","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/30883336","citation_count":24,"is_preprint":false},{"pmid":"30354217","id":"PMC_30354217","title":"Small GTPase Rap1A/B Is Required for Lymphatic Development and Adrenomedullin-Induced Stabilization of Lymphatic Endothelial Junctions.","date":"2018","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30354217","citation_count":23,"is_preprint":false},{"pmid":"1345809","id":"PMC_1345809","title":"Loss of heterozygosity at the human RAP1A/Krev-1 locus is a rare event in colorectal tumors.","date":"1992","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1345809","citation_count":22,"is_preprint":false},{"pmid":"24553435","id":"PMC_24553435","title":"Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24553435","citation_count":22,"is_preprint":false},{"pmid":"31805277","id":"PMC_31805277","title":"MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31805277","citation_count":21,"is_preprint":false},{"pmid":"33806572","id":"PMC_33806572","title":"Rap1a Overlaps the AGE/RAGE Signaling Cascade to Alter Expression of α-SMA, p-NF-κB, and p-PKC-ζ in Cardiac Fibroblasts Isolated from Type 2 Diabetic Mice.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33806572","citation_count":20,"is_preprint":false},{"pmid":"1315174","id":"PMC_1315174","title":"Reconstitution of defective respiratory burst activity with partially purified human neutrophil cytochrome B in two genetic forms of chronic granulomatous disease: possible role of Rap1A.","date":"1992","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/1315174","citation_count":20,"is_preprint":false},{"pmid":"31414345","id":"PMC_31414345","title":"Long noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma.","date":"2019","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/31414345","citation_count":19,"is_preprint":false},{"pmid":"27780730","id":"PMC_27780730","title":"miR-203a is involved in HBx-induced inflammation by targeting Rap1a.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27780730","citation_count":18,"is_preprint":false},{"pmid":"30848438","id":"PMC_30848438","title":"MicroRNA-340-5p relieved chronic constriction injury-induced neuropathic pain by targeting Rap1A in rat model.","date":"2019","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30848438","citation_count":17,"is_preprint":false},{"pmid":"36001955","id":"PMC_36001955","title":"Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36001955","citation_count":16,"is_preprint":false},{"pmid":"31545475","id":"PMC_31545475","title":"Rap1A promotes esophageal squamous cell carcinoma metastasis through the AKT signaling pathway.","date":"2019","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/31545475","citation_count":16,"is_preprint":false},{"pmid":"8084835","id":"PMC_8084835","title":"Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.","date":"1994","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/8084835","citation_count":16,"is_preprint":false},{"pmid":"20864093","id":"PMC_20864093","title":"Rap1A regulates generation of T regulatory cells via LFA-1-dependent and LFA-1-independent mechanisms.","date":"2010","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20864093","citation_count":16,"is_preprint":false},{"pmid":"29882482","id":"PMC_29882482","title":"Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.","date":"2018","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/29882482","citation_count":16,"is_preprint":false},{"pmid":"8216264","id":"PMC_8216264","title":"The Rap1A protein enhances protein kinase C activity in vitro.","date":"1993","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8216264","citation_count":16,"is_preprint":false},{"pmid":"22695258","id":"PMC_22695258","title":"Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory response.","date":"2012","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22695258","citation_count":16,"is_preprint":false},{"pmid":"9263124","id":"PMC_9263124","title":"Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1A, bound to the ras-binding domain of the raf-p74 protein: identification of effector domains in the raf protein.","date":"1997","source":"Journal of protein chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9263124","citation_count":16,"is_preprint":false},{"pmid":"30520098","id":"PMC_30520098","title":"miR-202 modulates the progression of neuropathic pain through targeting RAP1A.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30520098","citation_count":15,"is_preprint":false},{"pmid":"1573790","id":"PMC_1573790","title":"Co-deletions of the retinoblastoma gene and Wilms' tumor gene and rearrangement of the Krev-1 gene in a human insulinoma.","date":"1992","source":"Japanese journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/1573790","citation_count":15,"is_preprint":false},{"pmid":"9267439","id":"PMC_9267439","title":"Isolation and characterization of the krev-1 gene, a novel member of ras superfamily in Neurospora crassa: involvement in sexual cycle progression.","date":"1997","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/9267439","citation_count":14,"is_preprint":false},{"pmid":"8832211","id":"PMC_8832211","title":"Differential up-regulation of Rap1a and Rap1b proteins during smooth muscle cell cycle.","date":"1996","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8832211","citation_count":14,"is_preprint":false},{"pmid":"11602241","id":"PMC_11602241","title":"High-pressure NMR study of the complex of a GTPase Rap1A with its effector RalGDS. A conformational switch in RalGDS revealed from non-linear pressure shifts.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11602241","citation_count":14,"is_preprint":false},{"pmid":"39324266","id":"PMC_39324266","title":"Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel Mechanism Controlling NFAT-Mediated Vascular Inflammation and Permeability.","date":"2024","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/39324266","citation_count":13,"is_preprint":false},{"pmid":"35565390","id":"PMC_35565390","title":"TRPM8-Rap1A Interaction Sites as Critical Determinants for Adhesion and Migration of Prostate and Other Epithelial Cancer Cells.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35565390","citation_count":13,"is_preprint":false},{"pmid":"9882515","id":"PMC_9882515","title":"RAP1A GTP/GDP cycles determine the intracellular location of the late endocytic compartments and contribute to myogenic differentiation.","date":"1999","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9882515","citation_count":13,"is_preprint":false},{"pmid":"2116391","id":"PMC_2116391","title":"A domain responsible for the transformation suppressor activity in Krev-1 protein.","date":"1990","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/2116391","citation_count":13,"is_preprint":false},{"pmid":"32264665","id":"PMC_32264665","title":"microRNA-331-3p attenuates neuropathic pain following spinal cord injury via targeting RAP1A.","date":"2020","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/32264665","citation_count":12,"is_preprint":false},{"pmid":"37139869","id":"PMC_37139869","title":"Atorvastatin-mediated inhibition of prenylation of Rab27b and Rap1a in platelets attenuates their prothrombotic capacity and modulates clot structure.","date":"2023","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/37139869","citation_count":11,"is_preprint":false},{"pmid":"36691027","id":"PMC_36691027","title":"Extracellular matrix stiffness mediates uterine repair via the Rap1a/ARHGAP35/RhoA/F-actin/YAP axis.","date":"2023","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/36691027","citation_count":11,"is_preprint":false},{"pmid":"34067282","id":"PMC_34067282","title":"Rap1a Regulates Cardiac Fibroblast Contraction of 3D Diabetic Collagen Matrices by Increased Activation of the AGE/RAGE Cascade.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34067282","citation_count":11,"is_preprint":false},{"pmid":"10908723","id":"PMC_10908723","title":"Use of an activation-specific probe to show that Rap1A and Rap1B display different sensitivities to activation by forskolin in rat1 cells.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10908723","citation_count":11,"is_preprint":false},{"pmid":"1617222","id":"PMC_1617222","title":"Organization and chromosomal locations of Rap1a/Krev sequences in the mouse.","date":"1992","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/1617222","citation_count":10,"is_preprint":false},{"pmid":"32182086","id":"PMC_32182086","title":"Long noncoding RNA CRNDE promotes proliferation, migration and invasion in prostate cancer through miR-101/Rap1A.","date":"2020","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/32182086","citation_count":10,"is_preprint":false},{"pmid":"1501882","id":"PMC_1501882","title":"The functional domain of the stimulatory GDP/GTP exchange protein (smg GDS) which interacts with the C-terminal geranylgeranylated region of rap1/Krev-1/smg p21.","date":"1992","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1501882","citation_count":10,"is_preprint":false},{"pmid":"36791985","id":"PMC_36791985","title":"Rap1A accelerates homocysteine-induced ANA-1 cells inflammation via synergy of FoxO1 and DNMT3a.","date":"2023","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/36791985","citation_count":9,"is_preprint":false},{"pmid":"32948655","id":"PMC_32948655","title":"Functional and structural characterization of allosteric activation of phospholipase Cε by Rap1A.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32948655","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50334,"output_tokens":10468,"usd":0.154011,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21076,"output_tokens":5034,"usd":0.115615,"stage2_stop_reason":"end_turn"},"total_usd":0.269626,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Crystal structure of Rap1A (GppNHp-bound) in complex with the Ras-binding domain (RBD) of c-Raf1 resolved to 2.2 Å, showing that RBD adopts a ubiquitin superfold and that the interaction is mediated by an antiparallel beta-sheet formed between RBD strands B1-B2 and Rap1A strands β2-β3, with switch I effector residues of Rap1A providing main-chain and side-chain contacts.\",\n      \"method\": \"X-ray crystallography (2.2 Å resolution)\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with detailed interface description, landmark study widely replicated\",\n      \"pmids\": [\"7791872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Rap1A-p21 (Krev-1 product) binds tightly to Ras-GAP in a GTP-dependent manner but is not activated by GAP; it competitively inhibits GAP-mediated Ras GTPase activity, suggesting the mechanism by which Krev-1 suppresses Ras transformation.\",\n      \"method\": \"In vitro GTPase activity assay, competitive inhibition kinetics with purified proteins\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro biochemical reconstitution with purified proteins, foundational finding replicated across multiple labs\",\n      \"pmids\": [\"2164710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A is specifically activated (GTPase stimulated) by a dedicated Rap1-GAP purified from bovine brain (rap1GAP, 85–95 kDa); this GAP does not act on p21ras and is distinct from Ras-GAP, establishing a separate regulatory circuit for Rap1A.\",\n      \"method\": \"Biochemical purification from bovine brain, cDNA cloning, expression in Sf9 cells, in vitro GTPase stimulation assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — protein purified to homogeneity, cDNA cloned and expressed, in vitro GTPase assay with specificity controls\",\n      \"pmids\": [\"1904317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A is geranylgeranylated (C20 isoprenoid) at its COOH terminus in insect cells, in contrast to H-Ras which carries a farnesyl (C15) group, indicating that Rap1A is modified by a prenyl transferase distinct from farnesyl transferase; this COOH-terminal modification is required for membrane association.\",\n      \"method\": \"[3H]mevalonate labeling, baculovirus/Sf9 expression, SDS-PAGE, biochemical characterization of prenyl group\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct radiolabel incorporation with biochemical identification of lipid group, replicated and foundational\",\n      \"pmids\": [\"1899909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A associates stoichiometrically with cytochrome b558 (the membrane component of the NADPH oxidase system) in human neutrophils; GTP-bound Rap1A binds more tightly than GDP-bound form; phosphorylation of Rap1A by cAMP-dependent protein kinase (PKA) inhibits this binding.\",\n      \"method\": \"Biochemical co-purification, GTP-γS binding, in vitro PKA phosphorylation, binding assay with purified components\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — stoichiometric complex formation with purified proteins, nucleotide-dependence and phosphorylation effect directly tested\",\n      \"pmids\": [\"1763330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A is phosphorylated by cAMP-dependent protein kinase (PKA) on serine-180 in human neutrophils; this was established by amino acid sequence analysis of the purified protein, immunoprecipitation with a Rap1A-specific antibody, and mutagenesis of Ser-180.\",\n      \"method\": \"Electroporated neutrophils, [γ-32P]ATP labeling, immunoprecipitation, amino acid sequencing, carboxypeptidase digestion, site-directed mutagenesis (S180 mutant)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis confirming phosphorylation site, combined with protein purification and sequencing\",\n      \"pmids\": [\"1908879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Ras-Krev-1 chimera studies mapped the transformation-suppressing activity of Krev-1/Rap1A to a small cluster of amino acids immediately surrounding the effector domain (residues 32–44), suggesting Krev-1 suppresses Ras transformation by competing for Ras effector interactions.\",\n      \"method\": \"Chimeric protein construction, NIH 3T3 transformation assay, focus formation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic domain-swap mutagenesis with functional transformation readout, replicated concept\",\n      \"pmids\": [\"2115210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"A recombinant Rap1A with a Thr35→Ala mutation is unresponsive to Rap-GAP stimulation of GTPase activity, whereas wild-type Rap1A is activated by cytosolic Rap-GAP but not by Ras-GAP, demonstrating that the effector domain mediates GAP specificity.\",\n      \"method\": \"Baculovirus expression, in vitro GTPase assay, site-directed mutagenesis (T35A)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutant protein, clear mechanistic dissection of GAP specificity\",\n      \"pmids\": [\"2160589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Rap1A binds the Ras-binding domain of Ral-GEF (RGF-RBD) with high affinity (KD ~low nM range vs. ~1 µM for H-Ras), while H-Ras binds Raf-RBD with high affinity; binding of RGF-RBD to Rap1A is blocked by the D38A effector mutation and inhibits Rap-GAP interaction, indicating RalGEF is an effector of Rap1A rather than H-Ras.\",\n      \"method\": \"In vitro binding assay (guanine nucleotide dissociation inhibition), deletion mapping, mutagenesis (D38A), quantitative KD measurements\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative in vitro binding with mutagenesis controls, mechanistic specificity established\",\n      \"pmids\": [\"8636102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rap1A/Krev-1 binds strongly to a novel ankyrin repeat protein KRIT1 in a yeast two-hybrid screen; KRIT1 interacted with Krev-1 but only weakly with Ras, suggesting it is a specific Krev-1 effector. KRIT1 maps to 7q21-22 and is later identified as the CCM1 gene.\",\n      \"method\": \"Yeast two-hybrid screen of HeLa cDNA library, domain mapping\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — yeast two-hybrid identification replicated by independent CCM1 cloning paper\",\n      \"pmids\": [\"9285558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Mutations in KRIT1, the Krev-1/Rap1A-binding protein identified by two-hybrid, cause cerebral cavernous malformations (CCM1), establishing a direct link between the Rap1A signaling pathway and cerebrovascular disease/angiogenesis.\",\n      \"method\": \"Positional cloning, mutation identification in 23 CCM1 families, yeast two-hybrid confirmation of KRIT1-Rap1A interaction\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and biochemical evidence linking Rap1A pathway to cerebrovascular disease, though interaction itself tested by two-hybrid\",\n      \"pmids\": [\"10545614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A proteins are localized to the Golgi complex in mammalian cells; they do not colocalize with Ras proteins on the plasma membrane; this localization is conferred by the C-terminal CAAX region and is distinct from Ras.\",\n      \"method\": \"Indirect immunofluorescence (anti-Rap1 peptide antibodies), subcellular fractionation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — immunofluorescence and fractionation, replicated in subsequent studies\",\n      \"pmids\": [\"1900364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Rap1A and Rap1B proteins localize to late endocytic compartments (late endosomes/lysosomes) in fibroblasts, and also associate with phagosomes in macrophages, implicating Rap1A in late endocytic/phagocytic processes.\",\n      \"method\": \"Confocal immunofluorescence microscopy, subcellular fractionation, vaccinia T7 overexpression system\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — confocal microscopy and fractionation, two independent methods, single lab\",\n      \"pmids\": [\"7962206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Rap1A colocalizes with cytochrome b558 in plasma membrane and specific granule membranes of resting neutrophils; upon PMA stimulation, Rap1A cotranslocates with cytochrome b to the plasma membrane and to phagolysosomal membranes during phagocytosis.\",\n      \"method\": \"Subcellular fractionation, Western blotting, immunoelectron microscopy (double-labeling), quantitative ultrastructural analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (fractionation, immunoEM, quantitative colocalization), colocalization directly tied to functional NADPH oxidase assembly\",\n      \"pmids\": [\"1312373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rap1A binds the cysteine-rich region (CRR, residues 152-184) of Raf-1 with greatly enhanced affinity compared to Ha-Ras; this leads to co-association of Rap1A and Ha-Ras with Raf-1 N-terminus through CRR and RBD respectively, and Rap1A thereby interferes with Ras-dependent Raf-1 activation.\",\n      \"method\": \"In vitro binding assay, Sf9 baculovirus co-expression, Raf-1 kinase activation assay, mutagenesis (N26G, V45E, E31K)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro binding and functional kinase assay with mutagenesis, single lab but multiple methods\",\n      \"pmids\": [\"9115221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PKA phosphorylation of Rap1A at Ser-180 abolishes its binding to the Raf-1 cysteine-rich region (CRR) and prevents Rap1A from suppressing Ras-dependent Raf-1 activation; a phosphomimetic mutant S180E recapitulates this loss of suppressive function in COS-7 cells.\",\n      \"method\": \"In vitro binding assay, site-directed mutagenesis (S180E phosphomimetic), COS-7 cell co-transfection, Raf-1 kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphomimetic mutagenesis combined with in vitro binding and cellular functional assay\",\n      \"pmids\": [\"9867809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"AF-6 (afadin) binds Rap1A through its first Ras-binding domain more efficiently than oncogenic Ha-, K-, or N-Ras; Rap1A and Ras both interact with full-length AF-6 in mammalian cells and a fraction of Rap1A colocalizes with AF-6 at the membrane; AF-6 also associates with the actin regulator profilin.\",\n      \"method\": \"In vitro binding assay, co-immunoprecipitation in mammalian cells, immunofluorescence colocalization, MDCK and MCF-7 cell dominant-active Rap1A expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and in vitro binding, single lab, multiple methods\",\n      \"pmids\": [\"10922060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Constitutively active Rap1A in transgenic T cells does not antagonize Ras signaling or induce T cell anergy; instead, it enhances TCR-mediated responses and induces strong activation of β1 and β2 integrins via an avidity-modulation mechanism in vivo.\",\n      \"method\": \"Transgenic mouse model (constitutively active Rap1A in T cell lineage), T cell activation assays, integrin activation/adhesion assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic mouse model with multiple functional readouts, overturned previous model\",\n      \"pmids\": [\"11836528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Genetic deletion of Rap1A in mice causes impaired integrin-mediated adhesion of primary T and B cells to ICAM and fibronectin substrates, and impaired polarization of T cells after CD3 stimulation, confirming a role for Rap1A in integrin regulation in vivo.\",\n      \"method\": \"Homologous recombination knockout mouse, adhesion assays on ICAM/fibronectin, T cell polarization assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with defined cellular adhesion phenotype\",\n      \"pmids\": [\"16382154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rap1a-null mice show increased macrophage haptotaxis with decreased adhesion on fibronectin/vitronectin, reduced chemotaxis of lymphoid and myeloid cells to CXCL12/CCL21, increased FcR-mediated phagocytosis, and reduced fMLP-stimulated superoxide production in neutrophils, demonstrating non-redundant roles of Rap1a vs Rap1b.\",\n      \"method\": \"Rap1a gene deletion, macrophage haptotaxis/adhesion assays, chemotaxis assays, phagocytosis assay, superoxide production measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with multiple defined cellular phenotypes, isoform-specific effects established\",\n      \"pmids\": [\"18056377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RAP1A GTP/GDP cycling controls intracellular location of late endocytic compartments and contributes to myogenic differentiation; GDP-bound RAP1A clusters with acidic perinuclear structures and causes disturbances in cathepsin D maturation, while GTP-bound form inhibits and GDP-bound form promotes myotube formation.\",\n      \"method\": \"Stable cell lines expressing wild-type or mutant RAP1A, immunofluorescence, cathepsin D maturation assay, myogenic differentiation assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GTP/GDP mutants with multiple functional readouts, single lab\",\n      \"pmids\": [\"9882515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"JAM-A forms a complex with Afadin and PDZ-GEF2 to activate Rap1A, which in turn regulates β1 integrin protein levels and epithelial cell migration; knockdown of Rap1A (but not Rap1B) specifically decreased β1 integrin levels and reduced cell migration.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of Rap1A vs Rap1B, β1 integrin quantification, cell migration assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, isoform-specific siRNA knockdown with defined phenotypic readouts, single lab\",\n      \"pmids\": [\"19176753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Rap1a is required for FGF2-induced angiogenesis: rap1a−/− mice lack blood vessel growth into FGF2-containing Matrigel plugs and aortic rings fail to sprout; Rap1a/b knockdown in endothelial cells reduces adhesion, migration, tubular structure formation, and FGF2-induced ERK, p38, and Rac activation.\",\n      \"method\": \"Rap1a knockout mouse, Matrigel plug assay, aortic ring sprouting assay, siRNA knockdown in HMVECs, endothelial cell functional assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout combined with in vitro siRNA and multiple functional/signaling readouts\",\n      \"pmids\": [\"18625726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rap1A is the predominant isoform for endothelial junction formation and barrier function; Rap1A knockdown (not Rap1B) increases monolayer gaps and permeability; Rap1A localizes more strongly to junctions than Rap1B and co-immunoprecipitates more strongly with AF-6.\",\n      \"method\": \"miRNA-based isoform-specific knockdown, electrical impedance sensing, VE-cadherin immunostaining, GFP-tagged Rap1A/1B localization, co-immunoprecipitation\",\n      \"journal\": \"Small GTPases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods distinguishing isoforms, single lab\",\n      \"pmids\": [\"21776404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SHEP1, a novel SH2 domain-containing protein, directly couples activated EphB2 receptor to Rap1A and R-Ras (but not Ha-Ras or RalA) via its GEF-like domain, as demonstrated in a yeast two-hybrid screen and binding assays.\",\n      \"method\": \"Yeast two-hybrid screen, SH2 binding to phosphorylated EphB2, tyrosine phosphorylation of SHEP1 in cells expressing activated EphB2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — yeast two-hybrid identification with limited biochemical follow-up for Rap1A interaction\",\n      \"pmids\": [\"10542222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Rap1A (both GDP and GTP-bound forms) competitively inhibits the ability of Ras-GAP to block M2-muscarinic receptor-coupled K+ channel activation; a T35A effector-domain mutation abolishes this antagonism, confirming that the effector domain mediates Rap1A competition with GAP.\",\n      \"method\": \"Electrophysiology patch clamp, addition of purified Rap1A proteins, T35A mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro electrophysiology with purified proteins and mutagenesis, single lab\",\n      \"pmids\": [\"1939245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Heterogeneous amino acids in Ras and Rap1A carboxyl-terminal to the effector region determine sensitivity to different GAPs: residues 61–65 of Ras confer Ras-GAP sensitivity, while a larger set of Rap1A residues mediates sensitivity to cytoplasmic Rap-GAP; sensitivity to membrane Rap-GAP requires yet other residues.\",\n      \"method\": \"Chimeric protein construction, in vitro GTPase assay with different GAPs, NIH 3T3 transformation assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic chimera mutagenesis with in vitro GTPase assays, single lab\",\n      \"pmids\": [\"1749934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Purified recombinant Krev-1/Rap1A reconstitutes NADPH oxidase activity in immunodepleted neutrophil cytosol; H-Ras and yeast RAS proteins lack this activity; an antibody against the effector region (residues 31-43) of Krev-1 inhibits cell-free NADPH oxidase activation.\",\n      \"method\": \"Immunodepletion of cytosol, reconstitution with purified recombinant Krev-1, H-Ras controls, blocking antibody experiment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution with specificity controls, single lab\",\n      \"pmids\": [\"1906890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Dominant-negative (N17) and constitutively active (V12, GTPase-defective) mutants of Rap1A both inhibit superoxide production in differentiated HL60 cells, while overexpression of wild-type Rap1A increases O2−production fourfold, establishing that cycling between GDP- and GTP-bound forms is required for continuous NADPH oxidase activation.\",\n      \"method\": \"Stable transfection of HL60 cells with Rap1A mutants, differentiation to neutrophil-like cells, superoxide production assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple Rap1A mutants with functional NADPH oxidase assay, single lab\",\n      \"pmids\": [\"7833480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Active GTP-bound Rap1A translocates to the nucleus in squamous cell carcinoma cells, whereas inactive GDP-bound Rap1A is retained in the cytoplasm; nuclear translocation is induced by growth factors, as demonstrated by GFP-tagged constitutively active and inactive forms.\",\n      \"method\": \"GFP-tagging of active/inactive Rap1A, immunofluorescence, subcellular fractionation, immunohistochemistry on human cancer specimens\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GFP-fusion imaging with GTP/GDP-state-dependent localization, supported by IHC\",\n      \"pmids\": [\"13679863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Gβγ subunits of heterotrimeric G proteins form a complex with activated Rap1A and its effector Radil downstream of GPCR stimulation; Gβγ, activated Rap1A, and Radil promote translocation of Radil to the plasma membrane at sites of cell-matrix contact and are required for inside-out integrin activation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, integrin activation assay, live-cell imaging of Radil translocation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of endogenous complex with functional siRNA knockdown, single lab\",\n      \"pmids\": [\"20048162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KIF14 associates with the PDZ domain of the Rap1A effector Radil and tethers Radil on microtubules, negatively regulating Rap1A-mediated inside-out integrin activation; KIF14 depletion leads to increased cell spreading and altered focal adhesion dynamics.\",\n      \"method\": \"Co-immunoprecipitation, pulldown with PDZ domain, siRNA knockdown of KIF14, integrin activation assay, focal adhesion imaging, mouse xenograft\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical interaction mapping plus functional knockdown with cellular phenotype, single lab\",\n      \"pmids\": [\"23209302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PI3Kγ activates PLCγ → CalDAG-GEFI/II → Rap1A → RIAM pathway to induce integrin α4β1-mediated extravasation of myeloid cells; genetic depletion of Rap1A (but not constitutively active RapV12 which bypasses upstream signals) was sufficient to prevent integrin α4 activation and suppress myeloid cell recruitment to tumors.\",\n      \"method\": \"Genetic deletion/siRNA of pathway components in mouse, integrin activation assay, in vivo tumor inflammation model, epistasis analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in vivo with multiple pathway knockouts, single lab\",\n      \"pmids\": [\"23565202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"cAMP-Epac2-Rap1A-RhoA signaling in microvascular smooth muscle cells induces translocation of α2C-adrenoceptors from the Golgi/perinuclear region to the cell surface; this effect is impaired in Rap1A-null mouse microVSM and rescued by constitutively active Rap1A.\",\n      \"method\": \"Pharmacological activation of Epac/cAMP, Rap1A-null mouse microVSM, constitutively active Rap1A rescue, α2C-AR localization imaging\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — null mouse rescue experiment with functional receptor localization readout, single lab\",\n      \"pmids\": [\"22621783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"cAMP-Rap1A signaling facilitates translocation of α2C-adrenoceptors to the cell surface via filamin-2; yeast two-hybrid identified filamin-2 as an α2C-AR binding partner; Rap1A stimulation caused α2C-ARs to colocalize with filamin-2 on intracellular filaments and at the plasma membrane; filamin-2 knockdown inhibited Rap1-induced receptor surface delivery.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, site-directed mutagenesis, siRNA knockdown of filamin-2, confocal imaging\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (Y2H, co-IP, mutagenesis, siRNA) but single lab\",\n      \"pmids\": [\"23864608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Rap1A mediates thrombin (PAR-1)-stimulated glioblastoma cell adhesion to fibronectin and proliferation via a RhoA-PLD-Rap1A-β1 integrin pathway; siRNA knockdown of Rap1A (but not Rap1B) reduces tumor mass by >70% in mouse xenograft; Rap1A knockdown reduces phospho-FAK and phospho-ERK.\",\n      \"method\": \"siRNA knockdown of Rap1A vs Rap1B, cell adhesion assay, FAK/ERK phosphorylation, β1 integrin neutralization, mouse xenograft model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific siRNA, in vivo xenograft, multiple signaling readouts, single lab\",\n      \"pmids\": [\"24790104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rap1a activation by CalDAG-GEFI (Rasgrp2) and p38 MAPK (downstream of PLCγ2) is required for E-selectin-dependent slow leukocyte rolling and αLβ2 integrin activation; dominant-negative Rap1a blocked E-selectin-mediated slow rolling in Pik3cg−/− mice; Rasgrp2−/− mice lost E-selectin-dependent neutrophil recruitment.\",\n      \"method\": \"Intravital microscopy, Tat-fusion dominant-negative mutants, gene-deficient mice (Rasgrp2−/−, Pik3cg−/−), peritonitis model, biochemical studies\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with multiple knockout models and functional intravital imaging\",\n      \"pmids\": [\"21480213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Rap1A is required for lymphatic development: conditional knockout of Rap1a/b in lymphatic endothelial cells causes embryonic lethality with interstitial edema, blood-filled lymphatics, disrupted lymphovenous valves, and defective lymphangiogenesis; Rap1A/B knockdown disrupts junctional formation and impairs adrenomedullin-induced junctional tightening.\",\n      \"method\": \"Conditional knockout mouse (two independent lines), siRNA knockdown in human lymphatic endothelial cells, permeability assay, immunofluorescence\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent conditional knockout mouse lines with defined developmental phenotype and in vitro junctional assays\",\n      \"pmids\": [\"30354217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Rap1A allosterically activates phospholipase Cε (PLCε) by binding the RA2 domain; the PH domain and first two EF hands of PLCε are also required for Rap1A-mediated activation; hydrophobic residues on the RA2 surface are essential; SAXS shows Rap1A binding induces discrete conformational states in PLCε, providing the first structural evidence for allosteric activation.\",\n      \"method\": \"In vitro PLCε activity assay with purified proteins, mutagenesis (RA2 domain residues, PH, EF hands), small-angle X-ray scattering (SAXS), pulldown with purified proteins\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutagenesis and structural (SAXS) validation, multiple orthogonal methods in one study\",\n      \"pmids\": [\"32948655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Phosphorylation in the polybasic region (PBR) of Rap1A does not detectably inhibit its prenylation or binding to SmgGDS-607 (unlike Rap1B where S179/S180 phosphorylation inhibits these interactions); GPCR activation suppresses Rap1A prenylation but does not diminish Rap1A membrane localization, revealing isoform-specific regulation of prenylation.\",\n      \"method\": \"Binding assays (SmgGDS-607 interaction), mutagenesis of PBR residues, prenylation assays, GPCR stimulation experiments\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mutagenesis and binding assays, single lab, reveals mechanistic difference from Rap1B\",\n      \"pmids\": [\"27760305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Hepatocyte Rap1A activation suppresses gluconeogenic gene expression and hepatic glucose production via induction of actin polymerization that leads to Akt-mediated FoxO1 inhibition; Rap1A activity depends on geranylgeranylation for membrane localization; statins reduce Rap1A activity and stimulate hepatic gluconeogenesis; geranylgeraniol treatment restores Rap1A activity.\",\n      \"method\": \"Rap1a silencing and overexpression in hepatocytes, glucose production assay, actin polymerization assay, Akt/FoxO1 phosphorylation, statin treatment, geranylgeraniol rescue, obese mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional and signaling assays with rescue experiments, single lab\",\n      \"pmids\": [\"36001955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Rap1A knockdown in endothelial cells increases store-operated calcium entry (SOCE) through Orai1 channels, enhancing NFAT1 nuclear translocation and pro-inflammatory cytokine expression; EC-specific Rap1A knockout mice show inflammatory lung phenotype with increased permeability; siRNA-mediated Orai1 knockdown normalizes SOCE, NFAT activity, and barrier function in Rap1A-depleted cells and mice.\",\n      \"method\": \"siRNA knockdown of Rap1A vs Rap1B, whole-cell patch clamp (CRAC current), NFAT translocation assay, cytokine ELISA, EC-specific conditional Rap1A knockout mouse, lipid-nanoparticle siRNA delivery\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electrophysiology, genetic knockout mouse, mechanistic rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"39324266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TRPM8 channel directly interacts with Rap1A via specific residues (E207 and Y240 on TRPM8; Y32 on Rap1A); this interaction traps Rap1A in GDP-bound inactive form and inhibits cell migration and adhesion in prostate cancer cells; point mutations at these sites disrupt PPI and abolish the functional effects.\",\n      \"method\": \"Active Rap1 pull-down assay, GST-pulldown, co-immunoprecipitation, proximity ligation assay (PLA), molecular modeling, site-directed mutagenesis, live-cell imaging, migration/adhesion assays\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple interaction methods plus mutagenesis and functional assays, single lab\",\n      \"pmids\": [\"35565390\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The C-terminal geranylgeranylated region of Rap1A/Krev-1 is essential for interaction with smg GDS (guanine nucleotide exchange factor); mapping by cross-linking identified residues 444-492 of smg GDS as the domain interacting with the C-terminal region of Rap1A; deletion of these residues abolishes GDS activity on Rap1A.\",\n      \"method\": \"Cross-linking, site-directed mutagenesis/deletion of smg GDS, GDS exchange activity assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cross-linking and mutagenesis defining interaction domain, in vitro biochemical assay, single lab\",\n      \"pmids\": [\"1501882\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAP1A is a Ras-family small GTPase that is geranylgeranylated at its C-terminus for membrane localization, cycles between GDP- and GTP-bound states regulated by dedicated GAPs (rap1GAP) and GEFs (CalDAG-GEFI, Epac/smgGDS), and acts as a signaling hub that: (1) competes with Ras for GAP binding to suppress Ras-driven transformation; (2) activates integrins (β1, β2, α4β1, αLβ2) via effectors including RIAM and Radil to control cell adhesion, migration, and leukocyte trafficking; (3) is phosphorylated by PKA at Ser-180, which abolishes its binding to the Raf-1 cysteine-rich region and its Ras-suppressive function; (4) associates with cytochrome b558 of the NADPH oxidase to regulate superoxide production in phagocytes; (5) allosterically activates PLCε through its RA2 domain; (6) regulates endothelial junctions and lymphatic development; and (7) controls hepatic gluconeogenesis via actin polymerization and Akt/FoxO1 signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAP1A is a Ras-family small GTPase that cycles between GDP- and GTP-bound states to act as a signaling hub for cell adhesion, integrin activation, and vascular morphogenesis [#17, #18]. It is geranylgeranylated at its C-terminus, a modification distinct from the farnesylation of H-Ras that is required for membrane association and downstream activity, and which depends on smgGDS engagement of its C-terminal polybasic region [#3, #43, #40]. RAP1A nucleotide cycling is governed by a dedicated regulatory circuit: a Rap1-specific GAP that stimulates its GTPase but does not act on Ras, with GAP specificity dictated by effector-domain residues including Thr35 [#2, #7]. Structurally, GTP-loaded RAP1A engages effector Ras-binding domains through an antiparallel beta-sheet between its switch I region and the effector, the basis of its overlapping yet distinct effector repertoire relative to Ras [#0]. RAP1A binds tightly to Ras-GAP and to the Raf-1 cysteine-rich region, thereby competitively antagonizing Ras-driven Raf-1 activation and transformation; PKA phosphorylation at Ser-180 abolishes Raf-1 CRR binding and abrogates this suppressive function [#1, #14, #15, #6]. Beyond Ras antagonism, RAP1A selectively engages effectors such as RalGEF, KRIT1, and AF-6/afadin [#8, #9, #16]. In leukocytes it drives inside-out activation of \\u03b21, \\u03b22, \\u03b14\\u03b21, and \\u03b1L\\u03b22 integrins through CalDAG-GEFI and effectors RIAM and Radil to control adhesion, polarization, chemotaxis, and selectin-dependent rolling [#17, #18, #32, #36, #30]. RAP1A associates with cytochrome b558 of the NADPH oxidase and supports phagocyte superoxide production through GDP/GTP cycling [#4, #13, #27, #28]. In the endothelium and lymphatics it is the predominant isoform for junctional integrity and barrier function, is required for FGF2-induced angiogenesis and lymphatic development, and restrains store-operated calcium entry through Orai1 to limit inflammatory signaling [#23, #22, #37, #41]. Mutations in the RAP1A-binding effector KRIT1 cause cerebral cavernous malformations, linking this pathway to cerebrovascular disease [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing how Krev-1/Rap1A suppresses Ras transformation showed it acts by competing for Ras regulatory and effector interactions rather than by enzymatic activation.\",\n      \"evidence\": \"in vitro GTPase/competitive inhibition with purified proteins, plus Ras-Krev-1 chimera transformation assays in NIH 3T3 cells\",\n      \"pmids\": [\"2164710\", \"2115210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the dedicated GAP/GEF circuit\", \"Did not establish the physiological effectors mediating suppression\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Defining Rap1A's distinct regulatory and processing machinery established it as an autonomous GTPase circuit separate from Ras.\",\n      \"evidence\": \"purification of a Rap1-specific GAP from bovine brain, geranylgeranylation identified by mevalonate labeling, T35A mutant showing effector-domain control of GAP specificity, and chimera mapping of GAP-sensitivity residues\",\n      \"pmids\": [\"1904317\", \"1899909\", \"2160589\", \"1749934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GEFs activating Rap1A in vivo not yet defined\", \"Physiological output of the cycle not established\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Identifying Ser-180 as the PKA phosphorylation site and the cytochrome b558 association provided the first regulated functional readouts of Rap1A in phagocytes.\",\n      \"evidence\": \"32P-labeling, sequencing and S180 mutagenesis in neutrophils; stoichiometric co-purification with cytochrome b558 and nucleotide/phosphorylation-dependent binding; Golgi localization by immunofluorescence\",\n      \"pmids\": [\"1908879\", \"1763330\", \"1900364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Ser-180 phosphorylation not yet mapped to a specific effector\", \"Mechanism coupling Rap1A to oxidase assembly unresolved\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Reconstitution and mutant studies established that Rap1A GDP/GTP cycling is functionally required for NADPH oxidase activation, not merely correlated with it.\",\n      \"evidence\": \"reconstitution of immunodepleted neutrophil cytosol with recombinant Krev-1, blocking-antibody experiments, dominant-negative/constitutively-active Rap1A in HL60 cells, and immunoEM cotranslocation with cytochrome b\",\n      \"pmids\": [\"1906890\", \"7833480\", \"1312373\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GEF/GAP controlling oxidase-linked cycling not identified\", \"Direct catalytic contribution of Rap1A to electron transfer unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Quantitative effector binding distinguished the Rap1A and Ras effector repertoires, showing RalGEF binds Rap1A preferentially while Raf binds Ras.\",\n      \"evidence\": \"in vitro nucleotide-dissociation binding assays with KD measurements and D38A effector mutant\",\n      \"pmids\": [\"8636102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of Rap1A-RalGEF engagement not addressed\", \"In vivo relevance of effector partitioning not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Mapping Rap1A binding to the Raf-1 cysteine-rich region provided a structural mechanism for Ras antagonism, refined by the Rap1A-Raf RBD crystal structure.\",\n      \"evidence\": \"in vitro binding and Raf-1 kinase activation assays with mutagenesis; 2.2 Å crystal structure of GppNHp-Rap1A with Raf RBD\",\n      \"pmids\": [\"9115221\", \"7791872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CRR binding occurs at endogenous protein levels not shown\", \"Structural basis of full-length Raf engagement incomplete\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"PKA phosphorylation at Ser-180 was shown to abolish Raf-1 CRR binding and Ras-suppressive function, linking cAMP signaling to control of Rap1A's anti-Ras activity.\",\n      \"evidence\": \"in vitro binding and S180E phosphomimetic mutant with Raf-1 kinase assay in COS-7 cells\",\n      \"pmids\": [\"9867809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo kinetics of Ser-180 phosphorylation not quantified\", \"Effect on other Rap1A effectors not examined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Two-hybrid and positional cloning identified KRIT1 as a specific Rap1A effector and tied the pathway to cerebral cavernous malformations.\",\n      \"evidence\": \"yeast two-hybrid screen and positional cloning with mutation identification in CCM1 families\",\n      \"pmids\": [\"9285558\", \"10545614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction validated mainly by two-hybrid\", \"Mechanism by which Rap1A-KRIT1 signaling prevents malformations not established\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Transgenic and knockout mouse studies reframed Rap1A's principal in vivo role from Ras antagonist to integrin activator controlling lymphocyte adhesion and polarization.\",\n      \"evidence\": \"constitutively active Rap1A transgenic T cells and homologous-recombination Rap1A knockout with adhesion and polarization assays\",\n      \"pmids\": [\"11836528\", \"16382154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effectors linking Rap1A to integrins not fully defined in these studies\", \"Distinction from Rap1B not yet addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Clean Rap1a knockout established non-redundant, isoform-specific roles in myeloid/lymphoid adhesion, chemotaxis, phagocytosis, and superoxide production.\",\n      \"evidence\": \"Rap1a gene deletion with haptotaxis, chemotaxis, phagocytosis, and superoxide assays\",\n      \"pmids\": [\"18056377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of opposing adhesion/haptotaxis phenotypes unresolved\", \"Compensation by Rap1b not fully delineated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defining the upstream GEF cascades and effector adaptors clarified how Rap1A converts receptor signals into integrin activation during leukocyte trafficking.\",\n      \"evidence\": \"Gβγ-Rap1A-Radil complex co-IP and translocation imaging; CalDAG-GEFI/p38 epistasis in knockout mice with intravital microscopy; PI3Kγ-CalDAG-GEFI-RIAM epistasis in tumor recruitment models; KIF14-Radil tethering studies\",\n      \"pmids\": [\"20048162\", \"21480213\", \"23565202\", \"23209302\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of distinct GEFs in different cell types unresolved\", \"Structural basis of Radil/RIAM recruitment not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Vascular and lymphatic genetic models established Rap1A as the predominant isoform for endothelial junction integrity, angiogenesis, and lymphatic development.\",\n      \"evidence\": \"FGF2 Matrigel/aortic-ring assays in Rap1a knockouts; isoform-specific knockdown with impedance and VE-cadherin imaging; conditional lymphatic-EC knockout with developmental phenotyping\",\n      \"pmids\": [\"18625726\", \"21776404\", \"30354217\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Junctional effector(s) downstream of Rap1A only partly defined (AF-6)\", \"Mechanism distinguishing Rap1A from Rap1B at junctions incompletely resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Structural and biochemical work defined how Rap1A allosterically activates PLCε, identifying a new direct effector mechanism.\",\n      \"evidence\": \"in vitro PLCε activity assays with RA2/PH/EF-hand mutagenesis and SAXS conformational analysis\",\n      \"pmids\": [\"32948655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the active complex lacking\", \"Cellular signaling consequences of PLCε activation by Rap1A not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Recent work expanded Rap1A's endothelial role to restraint of store-operated calcium entry and metabolic control of hepatic gluconeogenesis.\",\n      \"evidence\": \"EC-specific Rap1A knockout with patch-clamp CRAC current, Orai1 rescue, and NFAT assays; hepatocyte Rap1a silencing/overexpression with glucose production, actin polymerization, Akt/FoxO1 readouts and statin/geranylgeraniol rescue\",\n      \"pmids\": [\"39324266\", \"36001955\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular link between Rap1A and Orai1 regulation not defined\", \"Effectors mediating actin-dependent Akt/FoxO1 control in hepatocytes unidentified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the dozens of Rap1A effectors and isoform-specific functions are coordinated and spatially partitioned across cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified map of effector selection across tissues\", \"GEF/GAP determinants of context-specific Rap1A versus Rap1B output unknown\", \"Structures of Rap1A bound to integrin-activation effectors (RIAM/Radil) lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 2, 7]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [17, 18, 30]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 14, 38]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [11, 33]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13, 23, 30]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [12, 20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 30, 36]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [18, 19, 32, 36]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [22, 37]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [18, 35]}\n    ],\n    \"complexes\": [\"NADPH oxidase (cytochrome b558 complex)\"],\n    \"partners\": [\"RAF1\", \"KRIT1\", \"MLLT4\", \"RALGDS\", \"RASA1\", \"RAP1GAP\", \"PLCE1\", \"RADIL\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":10,"faith_total":10,"faith_pct":100.0}}